Marycarmen Godinez victoria | Medicine | Research Excellence Award

Published on by Scientist Day

Global Scientist Day Awards

Marycarmen Godinez Victoria — Instituto Politecnico Nacional, Mexico
Marycarmen Godinez Victoria
Affiliation Instituto Politecnico Nacional
Country Mexico
Google Scholar DmXxCtYAAAAJ&hl
Documents 50
Citations 956
h-index 19
Subject Area Medicine
Event Global Scientist Day Awards
ORCID 0000-0003-3317-7980

Marycarmen Godinez Victoria is a medicine researcher affiliated with Instituto Politecnico Nacional in Mexico. The researcher profile supplied for this academic recognition page reports 50 documents, 956 citations, and an h-index of 19. These bibliometric indicators provide a structured view of the documented research record and can be considered alongside publication quality, research themes, collaboration, and broader scholarly contributions. The profile is associated with Google Scholar, Scopus, and ORCID identifiers, supporting researcher disambiguation across scholarly information systems. The Global Scientist Day Awards provides the recognition context for presenting this research profile and its associated academic record.[1] [2] [3]

Abstract

Marycarmen Godinez Victoria, affiliated with Instituto Politecnico Nacional in Mexico, is presented in this academic recognition profile as a researcher in medicine. The supplied scholarly record reports 50 documents, 956 citations, and an h-index of 19, alongside researcher identifiers in Google Scholar, Scopus, and ORCID. These indicators offer measurable evidence of scholarly activity and citation visibility, while the broader research record should be interpreted through publication context, methodological contributions, collaborations, and disciplinary relevance.[1] [2] [3]

Keywords

Marycarmen Godinez Victoria; Instituto Politecnico Nacional; Mexico; Medicine; medical research; scholarly publications; research impact; bibliometrics; Google Scholar; Scopus; ORCID; h-index; citations; Global Scientist Day Awards.

Introduction

Academic recognition profiles commonly combine institutional affiliation, disciplinary area, publication activity, citation indicators, and persistent researcher identifiers. Such information helps distinguish researchers with similar names and provides a reproducible framework for describing scholarly records. The supplied profile identifies Marycarmen Godinez Victoria with Instituto Politecnico Nacional, Mexico, and places the research field within medicine. [1] [2]

Research Profile

The supplied research profile identifies Marycarmen Godinez Victoria as a medicine researcher at Instituto Politecnico Nacional in Mexico. The reported record contains 50 documents, 956 citations, and an h-index of 19. Researcher identifiers supplied for this profile include Google Scholar, Scopus Author ID 35104790800, and ORCID 0000-0003-3317-7980, enabling cross-platform scholarly identification. [1] [2] [3]

Research Contributions

The available information establishes a sustained scholarly record in medicine, represented by 50 reported documents and measurable citation activity. These indicators describe the scale and visibility of the indexed research output but do not independently establish the significance of individual studies. A fuller assessment of contributions would consider research questions, methods, findings, collaborations, clinical or scientific relevance, and evidence of subsequent use by other researchers.

Publications

The supplied profile reports 50 scholarly documents associated with the researcher. The available information does not provide a complete publication-by-publication bibliography, journal list, or DOI inventory, so individual publication titles and DOI identifiers are not reproduced here. Scopus, Google Scholar, and ORCID can provide complementary mechanisms for locating and disambiguating publications, although their records may differ because of indexing coverage, author matching, and profile maintenance practices. [1] [2] [3]

Research Impact

The supplied bibliometric record reports 956 citations and an h-index of 19. Citation counts indicate that indexed scholarly works have been referenced by subsequent publications, while the h-index summarizes the relationship between publication count and citation thresholds. Such measures are discipline- and database-dependent and should therefore be considered as descriptive indicators rather than complete measures of research quality, societal relevance, or scientific influence. [1] [2]

Award Suitability

For the Global Scientist Day Awards, the documented profile provides several objective elements that may be relevant to an academic recognition review, including the stated medical research area, institutional affiliation, publication count, citation count, h-index, and persistent researcher identifiers. Final recognition should be determined according to the event’s published eligibility criteria, submission materials, verification procedures, and award committee assessment rather than bibliometric indicators alone. [2] [3]

Conclusion

Marycarmen Godinez Victoria is presented in the supplied academic record as a medicine researcher affiliated with Instituto Politecnico Nacional in Mexico. The reported profile includes 50 documents, 956 citations, and an h-index of 19, supported by Google Scholar, Scopus, and ORCID identifiers.

References

  1. Elsevier. (2026.). Scopus author details: Marycarmen Godinez Victoria, Author ID 35104790800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35104790800
  2. Google Scholar. (2026.). Marycarmen Godinez Victoria — Google Scholar Profile.
    https://scholar.google.com/citations?user=DmXxCtYAAAAJ&hl=en&oi=sra
  3. Stress modulates intestinal secretory immunoglobulin A.
    https://pubmed.ncbi.nlm.nih.gov/24348350/
  4. Global Scientist Day Awards. (2026). Global Scientist Day Awards — Official Website.
    https://scientistday.org/

Rolf Teschke | Precision Medicine | Best Academic Researcher Award

Published on by Scientist Day

Prof. Rolf Teschke | Precision Medicine | Best Academic Researcher Award

Prof. Rolf Teschke | Klinikum Hanau | Germany

Rolf Teschke, M.D., Professor of Medicine, is a distinguished German physician and internationally recognized expert in gastroenterology, hepatology, and the complex mechanisms of hepatotoxicity. Born in Gera, he pursued medical studies at the universities of Munich and Marburg, earning his medical degree and completing his inaugural thesis. His early scientific foundation was shaped in pathology, where his interest in liver injury and toxic mechanisms first took root. A pivotal stage of his career unfolded in New York, where he worked under the mentorship of renowned liver specialist Charles S. Lieber. During this period, he conducted influential biochemical research on alcohol-related liver injury, including solubilizing and isolating the microsomal ethanol-oxidizing system and exploring cytochrome P450–related pathways. This work strengthened his commitment to uncovering the biological foundations of hepatotoxicity and decisively shaped his future research direction. Returning to Germany, Professor Teschke continued to advance academically in gastroenterology, hepatology, and infectious diseases at the Heinrich Heine University of Düsseldorf. He completed his habilitation, received a prestigious university research award, and expanded his clinical and experimental work on alcohol-induced liver damage, hydrocarbon toxicity, and the growing challenge of drug-induced liver injury. As a department director at a major teaching hospital, he further deepened his focus on drug-induced liver injury, contributing significantly to the development and refinement of the RUCAM causality assessment method in collaboration with international experts. His scholarly output is substantial, consisting of more than 250 English-language publications, including books and book chapters. His work has earned 6,890 citations across 4,042 documents, with an h-index of 48, reflecting his strong influence in the global hepatology community. He has served as associate editor of Annals of Hepatology and held editorial roles across numerous leading medical and scientific journals.

Profile; Scopus | Orcid | Research Gate

Featured Publications:

Teschke, R. Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity. Review.
Annotation: Discusses two-step autoimmune hepatitis triggered by pharmaceutical agents, highlighting diagnostic and clinical implications.

Teschke, R. Acute Liver Failure with Determinate rather than Indeterminate Etiology Facilitates Therapy and May Avoid Liver Transplantation: A Critical Analysis. Review.
Annotation: Evaluates clinical outcomes in acute liver failure and argues the benefits of precise etiological identification.

Teschke, R., et al. Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms. Review.
Annotation: Compares two validated diagnostic algorithms to strengthen causality assessment in drug-induced autoimmune hepatitis.

Teschke, R. Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification. Review.
Annotation: Proposes an evidence-based immunological classification for idiosyncratic drug-induced liver injury (DILI).

Teschke, R., et al. Metabolic Mysteries of Copper Dysregulation in Wilson Disease. Review.
Annotation: Explores metabolic pathways and unresolved mechanisms underlying copper dysregulation in Wilson’s disease.

Teschke, R., et al. Open Questions on How Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes the Course of Drug-Induced Liver Injury. Letter.
Annotation: Raises key unresolved scientific and clinical questions on the interaction between MASLD and DILI.

Sylvia Mangani | Medical Discoveries | Best Researcher Award

Published on by Scientist Day

Ms. Sylvia Mangani | Medical Discoveries | Best Researcher Award

Ms. Sylvia Mangani | University of Patras | Greece

Sylvia Mangani is a biochemist–biotechnologist and PhD candidate in Biochemistry at the University of Patras, whose research centers on cancer biology, particularly the influence of the extracellular matrix on tumor growth and regulation through 3D cell culture systems. Her academic journey combines strong foundations in biochemistry and biotechnology (BSc, MSc) with advanced experimental and analytical expertise. Her work integrates a broad range of molecular and cellular biology techniques, including quantitative PCR, Western blotting, immunofluorescence, functional assays, and RNA sequencing, complemented by bioinformatics analysis for gene expression and signaling pathway interpretation. Her research has significantly contributed to understanding how 3D cellular microenvironments influence cancer progression, focusing on breast cancer models. She has authored 12 peer-reviewed publications in recognized international journals, with her work cited over 55 times according to Google Scholar, reflecting growing recognition within the scientific community. Her contributions have also supported award-winning synthetic biology initiatives under the iGEM program and have been presented at national and international scientific conferences. She has established productive collaborations with prominent research institutions in Greece and abroad. Notably, she completed a funded Erasmus+ research placement at the University Hospital of Münster, Germany, under the supervision of Prof. Martin Götte, where she engaged in experimental oncology projects exploring cancer cell behavior and matrix interactions. She has also collaborated with the National and Kapodistrian University of Athens on biochemical and molecular analyses within the Laboratory of Biochemistry, Biotechnology, and Molecular Analysis. A member of the Hellenic Society of Biochemistry and Molecular Biology (HSBMB), she actively contributes to the advancement of biochemical and cancer research in Greece and Europe. Her ongoing studies aim to deepen the understanding of tumor–matrix dynamics in breast cancer, offering new insights for therapeutic innovation and cancer model development, positioning her among emerging researchers in molecular oncology.

Profiles: Orcid | Google Scholar | LinkedIn | Research Gate

Featured Publications 

Mangani, S., Piperigkou, Z., Mangani, S., Koletsis, N. E., Koutsakis, C., Mastronikolis, N. S., Franchi, M., & Karamanos, N. K. (2025, August). Principal mechanisms of extracellular matrix‐mediated cell–cell communication in physiological and tumor microenvironments. The FEBS Journal. https://doi.org/10.1111/febs.70207

Mangani, S., Vetoulas, M., Mineschou, K., Spanopoulos, K., Vivanco, M. d. M., Piperigkou, Z., & Karamanos, N. K. (2025, July 15). Design and applications of extracellular matrix scaffolds in tissue engineering and regeneration. Cells, 14(14), 1076. https://doi.org/10.3390/cells14141076

Franchi, M., Masola, V., Onisto, M., Franchi, L., Mangani, S., Zolota, V., Piperigkou, Z., & Karamanos, N. K. (2025, July 7). Ultrastructural changes of the peri-tumoral collagen fibers and fibrils array in different stages of mammary cancer progression. Cells, 14(13), 1037. https://doi.org/10.3390/cells14131037

Karamanos, N. K., Piperigkou, Z., Gourdoupi, C., Mangani, S., & Vivanco, M. d. M. (2025, June 1). Extracellular matrix matters: Matrix-based bioscaffolds in advancing translational cancer research and targeted therapy. American Journal of Physiology-Cell Physiology, 328(6), C1235–C1251. https://doi.org/10.1152/ajpcell.00050.2025

Ciampelli, C., Mangani, S., Nieddu, G., Formato, M., Ioannou, P., Kremmydas, S., Karamanos, N., & Lepedda, A. J. (2025, March). Effects of acidic polysaccharide-enriched extracts from Holothuria tubulosa on two- and three-dimensional invasive breast cancer cell models. Biology, 14(4), 334. https://doi.org/10.3390/biology14040334

Mangani, S., Kremmydas, S., & Karamanos, N. K. (2025, March). Mimicking the complexity of solid tumors: How spheroids could advance cancer preclinical transformative approaches. Cancers, 17(7), 1161. https://doi.org/10.3390/cancers17071161